Trial
NCT02118311
Treg Cells for AGVHD in Non-myeloablative UCB Transplant
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Masonic Cancer Center, University of Minnesota
Collaborators
National Institutes of Health (NIH); National Cancer Institute (NCI)
Condition
Hematologic Malignancies
Intervention
T Regulatory cells
Why stopped
Changing study design. Will replace with a different protocol.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-12-02